Cardlytics (CDLX) Expected to Announce Earnings on Wednesday

Cardlytics (NASDAQ:CDLX - Get Free Report) is anticipated to announce its Q1 2025 earnings results after the market closes on Wednesday, May 7th. Analysts expect Cardlytics to post earnings of ($0.27) per share and revenue of $58.07 million for the quarter.

Cardlytics Stock Performance

Cardlytics stock traded up $0.31 during midday trading on Monday, hitting $2.15. The company's stock had a trading volume of 1,254,140 shares, compared to its average volume of 1,020,400. The company has a debt-to-equity ratio of 2.40, a current ratio of 1.18 and a quick ratio of 1.18. The company has a market cap of $111.91 million, a price-to-earnings ratio of -0.35 and a beta of 1.30. Cardlytics has a 1-year low of $1.22 and a 1-year high of $15.89. The company has a 50-day moving average price of $1.86 and a two-hundred day moving average price of $3.03.

Insider Transactions at Cardlytics

In other news, CFO Alexis Desieno sold 24,778 shares of the company's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total transaction of $84,245.20. Following the completion of the transaction, the chief financial officer now directly owns 140,948 shares in the company, valued at approximately $479,223.20. This represents a 14.95 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Amit Gupta sold 46,857 shares of the firm's stock in a transaction on Tuesday, February 18th. The shares were sold at an average price of $3.40, for a total value of $159,313.80. Following the sale, the chief executive officer now directly owns 418,637 shares in the company, valued at approximately $1,423,365.80. This trade represents a 10.07 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders sold 71,938 shares of company stock valued at $244,017. Corporate insiders own 4.40% of the company's stock.

Analyst Ratings Changes

CDLX has been the subject of a number of analyst reports. Lake Street Capital dropped their price target on shares of Cardlytics from $5.00 to $3.00 and set a "hold" rating for the company in a research report on Thursday, March 13th. Evercore ISI cut their target price on Cardlytics from $4.00 to $3.00 and set an "in-line" rating for the company in a research report on Thursday, March 13th. Finally, Needham & Company LLC restated a "hold" rating on shares of Cardlytics in a research report on Thursday, March 13th. One equities research analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a strong buy rating to the stock. According to data from MarketBeat.com, the company presently has an average rating of "Hold" and a consensus price target of $6.42.

Cardlytics Company Profile

Cardlytics, Inc operates an advertising platform in the United States and the United Kingdom. It offers Cardlytics platform, a proprietary native bank advertising channel that enables marketers to reach customers through their network of financial institution partners through digital channels, such as online, mobile applications, email, and various real-time notifications; and Bridg platform, a customer data platform which utilizes point-of-sale data and enables marketers to perform analytics and targeted loyalty marketing, as well as measure the impact of their marketing.